SlideShare a Scribd company logo
1
Forward-Looking	Statements
OTCQB:	CDIF
A	Public	Holding	Company	Providing Private	Companies an	Equity	
Exit Strategy	and	Equity	Capitalization Platform.
www.CardiffUSA.com
2Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Forward-Looking	Statements
This	presentation	contains	forward	looking	statements	within	the	
meaning	of	the	Securities	Litigation	Reform	Act.	The	statements	
reflect	the	Company's	current	views	with	respect	to	future	events	
that	involve	risks	and	uncertainties.	These	risks	include	the	failure	
to	meet	schedule	or	performance	requirements	of	the	Company's	
contracts,	the	Company's	liquidity	position,	the	Company's	ability	
to	obtain	new	contracts,	the	emergence	of	competitors	with	
greater	financial	resources,	and	the	impact	of	competitive	pricing.	
In	the	light	of	these	uncertainties	the	forward-looking	events	
referred	to	in	this	presentation	might	not	occur.
3Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Overview
We	are	a	mini	Berkshire	Hathaway	for	companies	
under	$100	million	in	revenue.
• $100k	Revenue	in	2015
• $4M	Revenue	in	2016
• $17+M	Revenue	in	2017	if	No	Additional	Acquisitions
• $40+M	Additional	Revenue	in	Pending	Acquisitions
Cardiff	currently	has	11	subsidiaries	at	$17M	annualized	revenue	with	less	than	$1M	debt	
and	1	pending	$10M	acquisitions	under	LOI	with	3	more	qualified	
$30M	acquisitions	awaiting	funding.
4Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Financials
$0
$2
$4
$6
$8
$10
$12
2014 2015 2016 2017
Revenue
(in	millions)
**
*	Pro-forma	revenue	forecast
5Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Key	Facts
Exchange:	Ticker OTCQB: CDIF
Recent	Price $0.16
Market	Cap $5.8 million
Shares	Outstanding 34.4	million
Float 17.4	million
Revenue ~$4	million
Fiscal	Year December 31
6Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Management
DR.	ROLLAN	ROBERTS,	II	– COO/SVP
From	turning	around	large,	established	companies	to	creating	high	growth	revenue	
organizations,	Dr.	Roberts	has	passionately	led	with	excellence	a	multi-billion,	
publicly-held	database	company	along	with	healthcare,	technology,	manufacturing	
and	direct	sales	companies.	 He	has	led	nearly	1500	employees	at	a	given	time	
servicing	clients	such	as	Capital	One,	IndyMac	Bank,	State	Farm,	Allstate,	Nationwide	
along	with	federal	and	state	government	agencies.	
ALEX CUNNINGHAM – CEO/PRESIDENT/DIRECTOR
Mr.	Cunningham’s	has	led	senior	management	in	multiple	companies	and	created	
and	implemented	growth	and	efficiency	strategies	for	client	companies.	He	is	the	
founder	of	multiple	consulting	firms	where	he	managed	projects	and	a	staff	of	85	
helping	2000	private	or	closely	held	middle-market	client	companies	in	24	states.	He	
was	a	partner	at	M&A	firm	London	Capital	Corporation	where	he	managed	all	
phases	of	the	transaction	process.
DANIEL R. THOMPSON –CHAIRMAN OF THE BOARD
Appointed	Chairman/CEO	in	2010.	30-year	career	that	embraces	network	and	cable	
advertising	sales,	programming	production	and	product	placement.	Thompson	also	
founded Creative	Entertainment	Services,	which	he	successfully	sold	in	2001.	Mr.	
Thompson	also	founded	Cable	Rep	USA,	a	media	sales	firm	specializing	in	local	
market	cable	advertising,	which	he	sold	to	Cox	Cable	in	1981.
7Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Current	Holdings
• Repicci’s Italian	Ice	&	Gelato
$3M	revenue	run-rate
• American	Cycle	Finance
$17M	revenue	run-rate
• CSSC/Decision	Technology	Corp.
$10M	revenue	run-rate
• Romeo’s	Pizza
$800K	revenue	run-rate
• Affordable	Housing	Initiative
$400K	revenue	run-rate
• Edge	View	Properties
30	Acres	Prime	Commercial	Real	Estate
• Mission	Tuition
Massive	Merchant	Shopping	Network
8Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Market	Opportunity
u Target 1: Gourmet Super Markets, Value $31M, Revenue $45M, Earnings $5.2M
u Target 2: Real Estate Related to Target 2, Value of $51.5M- Generates $6.6M
u Target 3: Mobile Home Park, 47 Corporate owned units, Value of $3.2M
u Target 4: Rapid Growth Dental Chain, 14 Locations. Value of $12,000,000.
u Target 5: Nutraceutical Manufacturer, Value of $5,550,000 - Generates $650,000
u Target 6: Pharma Grade Nutraceutical Spinoff, Value of $3,500,000
TOTAL	ADDITIONAL	REVENUE:		$68,000,000
with	$25M	cash/stock	deals
9Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Market	Problem
1. Struggle	to	sell	their	Business	in	Smaller	
Markets.
- The	more	profitable,	the	less	likely	they	are	to	find	
a	buyer.
2. Struggle	Getting	Market	Value.
3. Struggle	Getting	Financing	to	Grow	the	
Business
4. Struggle	Getting	Investment	to	Reduce	
Debt	&	Reduce	Operating	Costs
Profitable	private	companies	in	sub-prime	markets	struggle.
10Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Cardiff	Solution
1. We	provide	an	“Equity	Exit	Strategy”	for	
business	owners.
2. We	provide	an	“Equity	Capitalization	
Strategy”	for	business	owners.
Cardiff	solves	two	key	problems	most	private	companies	face:
Cardiff	employs	a	merge,	acquire,	and	hold	strategy.
11Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Our	Value	Add
Cardiff	adds	value	to	subsidiaries	by:
• Improving	balance	sheets;	novating debt
• Supporting	high	growth	companies
• Providing	strategic	and	operational	guidance
• Forming	synergies	amongst	acquisitions
• Gaining	economies	of	scale
• Reducing	investor	and	owner	risks	by	spreading	it	across	
entire	Cardiff	portfolio
12Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Cardiff	Focus
• Management
• Market
• Margin
Cardiff’s	highly	curated	approach	targets:
Cardiff	targets	acquisitions	of	mature,	high	growth,	niche	companies.
1. Acquisitions; Closely Held Companies
2. Income Producing Real Estate
3. Second Stage Startups
WITH	STRONG...
13Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Acquisition	Process
VALUATION LOI DUE	
DILIGENCE
AGREEMENT	
EXECUTED
AUDIT SHARES	
ISSUED
*
“Qualified”	Preferred	Stock	 100%	of	the	“vote	and	value”	
of	the	company’s	stock
• Exclusive	series	of	Preferred	Stock	awarded	to	each	company	
• Non-voting	sub-class	authorized	for	the	purpose	of	raising	working	capital
• Acquisitions	added	to	Cardiff’s	consolidated	balance	sheet,	creating	tangible	value	for	all	parties
• Acquisition	assets	are	not	co-mingled,	and	operational	autonomy	is	maintained.
*	Preferred	shares	are	issued	under	IRS	Section	368(a)1(B)	
guidelines	(Tax-Free	Exchange)	
votes	for	control	of	the	
newly	acquired	company
14Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Largest	Financial	Investors
• Gary	Teel,	Co-Founder	 $2.0M
• Daniel	R	Thompson,	Chairman/Co-Founder	 $1.8M
• Peggy	Scheer, Financial	Advisor	 $1.2M
• Alex	Cunningham,	President	&	CEO	 $1.0M
• James	Cameron	&	Family,	Movie	Producer/Director	 $1.0M
• Steve	Posner	Family,	Florida	Real	Estate	Developer	 $600K
• Richard	Duffy,	Morgan	Stanley	 $550K
15Cardiff	International,	Inc.	(OTCQB:	CDIF)	|		2017
Corporate	Outlook
§ Positioned	for	$20M+	revenue	with	profitability	in	2017
§ 2017	Anticipated	2nd Qtr.	Market	Cap	- $15M; Year	End	
$100M
§ 3	near-term	acquisition	targets	add	significant	additional	
revenue	upside
§ Strong	management	team	with	history	of	execution
§ Focused,	disciplined	investment	strategy
16Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Year	Over	Year
Tremendous	Performance	Year	over	Year
u .08	Cents
u $2.6	Million
u 3	Million
u ~6,000	Shares
April	2016 April	2017
Taking	Main	Street	to	Wall	Street!
u .17	Cents
u $5.8	Million
u 17	Million
u ~130,000	Shares
Share	Price
Market	Cap
Float
Trading	Volume
17Cardiff	International,	Inc.	(OTCQB:	CDIF)	|	2017
Accredited	Investor	Offering
$25K	minimum
u $50M	Subsidiary	Asset	Acquisition
u Existing	Subsidiary	Expansion
u Planning/positioning	for	NASDAQ	
USE	OF	FUNDS
SHARE	PRICE	GROWTH
0
0.1
0.2
0.3
0.4
0.5
9/20/16 10/20/16 11/20/16 12/20/16 1/20/17
CDIF	Historical	Chart
High Low Close
HIGHLIGHTS
u 1:1.5	Conversion	Rate
u 20%	Discount	on	Stock
u Make	Whole	Provision
u Warranties
18
Forward-Looking	Statements
Corporate	Offices:
401	East	Las	Olas	Boulevard
Unit	1400
Fort	Lauderdale,	FL	33301
United	States
p:	844-628-2100
www.CardiffUSA.com
OTCQB:	CDIF

More Related Content

What's hot

AWK Investor Presentation
AWK Investor PresentationAWK Investor Presentation
AWK Investor Presentation
RedChip Companies, Inc.
 
Bausch + Lomb Acquisition Conference Call
Bausch + Lomb Acquisition Conference CallBausch + Lomb Acquisition Conference Call
Bausch + Lomb Acquisition Conference Call
Valeant_Pharmaceuticals
 
Healthcare Investment and Exits Report - 2018
Healthcare Investment and Exits Report - 2018Healthcare Investment and Exits Report - 2018
Tsn investor presentation march 2017
Tsn investor presentation march 2017Tsn investor presentation march 2017
Tsn investor presentation march 2017
investortyson
 
Investor Presentation August 2013
Investor Presentation August 2013Investor Presentation August 2013
Investor Presentation August 2013
Intact
 
Nvta cantor sept 2017
Nvta cantor sept 2017Nvta cantor sept 2017
Nvta cantor sept 2017
invitaeir
 
Investor presentation-november-2014 v001-j60qin
Investor presentation-november-2014 v001-j60qinInvestor presentation-november-2014 v001-j60qin
Investor presentation-november-2014 v001-j60qin
Intact
 
20150218 investor document 4 q final2
20150218 investor document 4 q final220150218 investor document 4 q final2
20150218 investor document 4 q final2
Valeant_Pharmaceuticals
 
Ifc investor-presentation-(september-2016)
Ifc investor-presentation-(september-2016)Ifc investor-presentation-(september-2016)
Ifc investor-presentation-(september-2016)
Intact
 
Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017
RedChip Companies, Inc.
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
Valeant_Pharmaceuticals
 
Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013
Intact
 
Invitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
Invitae's 36th Annual J.P. Morgan Healthcare Conference PresentationInvitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
Invitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
invitaeir
 
Cah q4 fy17 presentation
Cah q4 fy17 presentationCah q4 fy17 presentation
Cah q4 fy17 presentation
Cardinal_Health
 
Valeant Pharmaceuticals' Investor Day 2012 Download
Valeant Pharmaceuticals' Investor Day 2012 DownloadValeant Pharmaceuticals' Investor Day 2012 Download
Valeant Pharmaceuticals' Investor Day 2012 DownloadValeant_Pharmaceuticals
 
RxLogic Pitch Deck 112216
RxLogic Pitch Deck 112216RxLogic Pitch Deck 112216
RxLogic Pitch Deck 112216Scott J. Hopper
 
Investor presentation sept.oct_2010_r
Investor presentation sept.oct_2010_rInvestor presentation sept.oct_2010_r
Investor presentation sept.oct_2010_rIntact
 
Jefferies 2015 final
Jefferies 2015 finalJefferies 2015 final
Jefferies 2015 final
Valeant_Pharmaceuticals
 
Investor presentation-may-2015 v001-p70xic
Investor presentation-may-2015 v001-p70xicInvestor presentation-may-2015 v001-p70xic
Investor presentation-may-2015 v001-p70xic
Intact
 

What's hot (20)

AWK Investor Presentation
AWK Investor PresentationAWK Investor Presentation
AWK Investor Presentation
 
Bausch + Lomb Acquisition Conference Call
Bausch + Lomb Acquisition Conference CallBausch + Lomb Acquisition Conference Call
Bausch + Lomb Acquisition Conference Call
 
Investor Present 04202017
Investor Present  04202017Investor Present  04202017
Investor Present 04202017
 
Healthcare Investment and Exits Report - 2018
Healthcare Investment and Exits Report - 2018Healthcare Investment and Exits Report - 2018
Healthcare Investment and Exits Report - 2018
 
Tsn investor presentation march 2017
Tsn investor presentation march 2017Tsn investor presentation march 2017
Tsn investor presentation march 2017
 
Investor Presentation August 2013
Investor Presentation August 2013Investor Presentation August 2013
Investor Presentation August 2013
 
Nvta cantor sept 2017
Nvta cantor sept 2017Nvta cantor sept 2017
Nvta cantor sept 2017
 
Investor presentation-november-2014 v001-j60qin
Investor presentation-november-2014 v001-j60qinInvestor presentation-november-2014 v001-j60qin
Investor presentation-november-2014 v001-j60qin
 
20150218 investor document 4 q final2
20150218 investor document 4 q final220150218 investor document 4 q final2
20150218 investor document 4 q final2
 
Ifc investor-presentation-(september-2016)
Ifc investor-presentation-(september-2016)Ifc investor-presentation-(september-2016)
Ifc investor-presentation-(september-2016)
 
Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017
 
Valeant Investor Day 2015 Presentation
Valeant Investor Day 2015 PresentationValeant Investor Day 2015 Presentation
Valeant Investor Day 2015 Presentation
 
Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013Presentation aux investisseurs (anglais seulement) mai 2013
Presentation aux investisseurs (anglais seulement) mai 2013
 
Invitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
Invitae's 36th Annual J.P. Morgan Healthcare Conference PresentationInvitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
Invitae's 36th Annual J.P. Morgan Healthcare Conference Presentation
 
Cah q4 fy17 presentation
Cah q4 fy17 presentationCah q4 fy17 presentation
Cah q4 fy17 presentation
 
Valeant Pharmaceuticals' Investor Day 2012 Download
Valeant Pharmaceuticals' Investor Day 2012 DownloadValeant Pharmaceuticals' Investor Day 2012 Download
Valeant Pharmaceuticals' Investor Day 2012 Download
 
RxLogic Pitch Deck 112216
RxLogic Pitch Deck 112216RxLogic Pitch Deck 112216
RxLogic Pitch Deck 112216
 
Investor presentation sept.oct_2010_r
Investor presentation sept.oct_2010_rInvestor presentation sept.oct_2010_r
Investor presentation sept.oct_2010_r
 
Jefferies 2015 final
Jefferies 2015 finalJefferies 2015 final
Jefferies 2015 final
 
Investor presentation-may-2015 v001-p70xic
Investor presentation-may-2015 v001-p70xicInvestor presentation-may-2015 v001-p70xic
Investor presentation-may-2015 v001-p70xic
 

Similar to CDIF investor presentation

CDIF Investor Presentation.2017.red chip
CDIF Investor Presentation.2017.red chipCDIF Investor Presentation.2017.red chip
CDIF Investor Presentation.2017.red chip
RedChip Companies, Inc.
 
Cdif investor deck jan 2017 final
Cdif investor deck jan 2017 finalCdif investor deck jan 2017 final
Cdif investor deck jan 2017 final
RedChip Companies, Inc.
 
Cardiff International, Inc. Investor Deck
Cardiff International, Inc. Investor DeckCardiff International, Inc. Investor Deck
Cardiff International, Inc. Investor Deck
RedChip Companies, Inc.
 
October Investor Presentation
October Investor PresentationOctober Investor Presentation
October Investor Presentation
Devon Energy Corporation
 
Q2 fy17-earnings-presentation v-final
Q2 fy17-earnings-presentation v-finalQ2 fy17-earnings-presentation v-final
Q2 fy17-earnings-presentation v-final
ir_westrock
 
August Investor Presentation
August Investor PresentationAugust Investor Presentation
August Investor Presentation
Devon Energy Corporation
 
Dvn aug-2018-investor-presentation
Dvn aug-2018-investor-presentationDvn aug-2018-investor-presentation
Dvn aug-2018-investor-presentation
Devon Energy Corporation
 
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call PresentationQ3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call Presentation
Sysco_Investors
 
Dvn july-2018-investor-presentation
Dvn july-2018-investor-presentationDvn july-2018-investor-presentation
Dvn july-2018-investor-presentation
Devon Energy Corporation
 
Wrk mar 2017 investor presentation final
Wrk mar 2017 investor presentation finalWrk mar 2017 investor presentation final
Wrk mar 2017 investor presentation final
ir_westrock
 
DSS Presentation Deck Dec 2021
DSS Presentation Deck  Dec 2021DSS Presentation Deck  Dec 2021
DSS Presentation Deck Dec 2021
RedChip Companies, Inc.
 
JP Morgan Energy Presentation
JP Morgan Energy PresentationJP Morgan Energy Presentation
JP Morgan Energy Presentation
Devon Energy Corporation
 
June Investor Presentation
June Investor PresentationJune Investor Presentation
June Investor Presentation
Devon Energy Corporation
 
Venture-Pulse-Report-Q2-2016
Venture-Pulse-Report-Q2-2016Venture-Pulse-Report-Q2-2016
Venture-Pulse-Report-Q2-2016JohnMFreeborn
 
PRO_CaseStudy_Aspiriant
PRO_CaseStudy_AspiriantPRO_CaseStudy_Aspiriant
PRO_CaseStudy_AspiriantJoseph Clark
 
LendingClub Stockholder Outreach 2019 Presentation
LendingClub Stockholder Outreach 2019 PresentationLendingClub Stockholder Outreach 2019 Presentation
LendingClub Stockholder Outreach 2019 Presentation
Tearsheet
 
September Investor Presentation
September Investor PresentationSeptember Investor Presentation
September Investor Presentation
Devon Energy Corporation
 
Quantifi newsletter Insight jan 2011
Quantifi newsletter Insight jan 2011Quantifi newsletter Insight jan 2011
Quantifi newsletter Insight jan 2011
Quantifi
 
2023 Barclays Global Consumer Staples Conference.pdf
2023 Barclays Global Consumer Staples Conference.pdf2023 Barclays Global Consumer Staples Conference.pdf
2023 Barclays Global Consumer Staples Conference.pdf
SYYIR
 

Similar to CDIF investor presentation (20)

CDIF Investor Presentation.2017.red chip
CDIF Investor Presentation.2017.red chipCDIF Investor Presentation.2017.red chip
CDIF Investor Presentation.2017.red chip
 
Cdif investor deck jan 2017 final
Cdif investor deck jan 2017 finalCdif investor deck jan 2017 final
Cdif investor deck jan 2017 final
 
Cardiff International, Inc. Investor Deck
Cardiff International, Inc. Investor DeckCardiff International, Inc. Investor Deck
Cardiff International, Inc. Investor Deck
 
October Investor Presentation
October Investor PresentationOctober Investor Presentation
October Investor Presentation
 
Q2 fy17-earnings-presentation v-final
Q2 fy17-earnings-presentation v-finalQ2 fy17-earnings-presentation v-final
Q2 fy17-earnings-presentation v-final
 
August Investor Presentation
August Investor PresentationAugust Investor Presentation
August Investor Presentation
 
Dvn aug-2018-investor-presentation
Dvn aug-2018-investor-presentationDvn aug-2018-investor-presentation
Dvn aug-2018-investor-presentation
 
Q3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call PresentationQ3 FY24 Earnings Conference Call Presentation
Q3 FY24 Earnings Conference Call Presentation
 
Dvn july-2018-investor-presentation
Dvn july-2018-investor-presentationDvn july-2018-investor-presentation
Dvn july-2018-investor-presentation
 
Wrk mar 2017 investor presentation final
Wrk mar 2017 investor presentation finalWrk mar 2017 investor presentation final
Wrk mar 2017 investor presentation final
 
DSS Presentation Deck Dec 2021
DSS Presentation Deck  Dec 2021DSS Presentation Deck  Dec 2021
DSS Presentation Deck Dec 2021
 
JP Morgan Energy Presentation
JP Morgan Energy PresentationJP Morgan Energy Presentation
JP Morgan Energy Presentation
 
June Investor Presentation
June Investor PresentationJune Investor Presentation
June Investor Presentation
 
Venture-Pulse-Report-Q2-2016
Venture-Pulse-Report-Q2-2016Venture-Pulse-Report-Q2-2016
Venture-Pulse-Report-Q2-2016
 
PRO_CaseStudy_Aspiriant
PRO_CaseStudy_AspiriantPRO_CaseStudy_Aspiriant
PRO_CaseStudy_Aspiriant
 
LendingClub Stockholder Outreach 2019 Presentation
LendingClub Stockholder Outreach 2019 PresentationLendingClub Stockholder Outreach 2019 Presentation
LendingClub Stockholder Outreach 2019 Presentation
 
September Investor Presentation
September Investor PresentationSeptember Investor Presentation
September Investor Presentation
 
Quantifi newsletter Insight jan 2011
Quantifi newsletter Insight jan 2011Quantifi newsletter Insight jan 2011
Quantifi newsletter Insight jan 2011
 
C.A. Bancorp Inc. 2007 Annual Report
C.A. Bancorp Inc. 2007 Annual ReportC.A. Bancorp Inc. 2007 Annual Report
C.A. Bancorp Inc. 2007 Annual Report
 
2023 Barclays Global Consumer Staples Conference.pdf
2023 Barclays Global Consumer Staples Conference.pdf2023 Barclays Global Consumer Staples Conference.pdf
2023 Barclays Global Consumer Staples Conference.pdf
 

More from RedChip Companies, Inc.

ZOM Investor Presentations Oct 2023
ZOM Investor Presentations Oct 2023ZOM Investor Presentations Oct 2023
ZOM Investor Presentations Oct 2023
RedChip Companies, Inc.
 
Docola Presentation
Docola PresentationDocola Presentation
Docola Presentation
RedChip Companies, Inc.
 
INNO Holdings Presentation
INNO Holdings PresentationINNO Holdings Presentation
INNO Holdings Presentation
RedChip Companies, Inc.
 
EBI IR Presentation Sep 2023
EBI IR Presentation Sep 2023EBI IR Presentation Sep 2023
EBI IR Presentation Sep 2023
RedChip Companies, Inc.
 
ASPI Investor Deck Oct 2023
ASPI Investor Deck Oct 2023ASPI Investor Deck Oct 2023
ASPI Investor Deck Oct 2023
RedChip Companies, Inc.
 
MDNA Investor Presentation May 2023
MDNA Investor Presentation May 2023MDNA Investor Presentation May 2023
MDNA Investor Presentation May 2023
RedChip Companies, Inc.
 
DGLY Corporate Investor Relations Deck Oct 2023
DGLY Corporate Investor Relations Deck Oct 2023DGLY Corporate Investor Relations Deck Oct 2023
DGLY Corporate Investor Relations Deck Oct 2023
RedChip Companies, Inc.
 
Lantern Pharma Investor Presentation Oct 2023
Lantern Pharma Investor Presentation Oct 2023Lantern Pharma Investor Presentation Oct 2023
Lantern Pharma Investor Presentation Oct 2023
RedChip Companies, Inc.
 
Sharps Investor Deck Oct 2023
Sharps Investor Deck Oct 2023 Sharps Investor Deck Oct 2023
Sharps Investor Deck Oct 2023
RedChip Companies, Inc.
 
Aditxt, Inc. (NASDAQ: ADTX) Presentation
Aditxt, Inc. (NASDAQ: ADTX) PresentationAditxt, Inc. (NASDAQ: ADTX) Presentation
Aditxt, Inc. (NASDAQ: ADTX) Presentation
RedChip Companies, Inc.
 
1847 Holdings Corporate Presentation 1847 Holdings March 2023
1847 Holdings Corporate Presentation 1847 Holdings March 20231847 Holdings Corporate Presentation 1847 Holdings March 2023
1847 Holdings Corporate Presentation 1847 Holdings March 2023
RedChip Companies, Inc.
 
Sharps Investor Presentation October 2023
Sharps  Investor Presentation October 2023Sharps  Investor Presentation October 2023
Sharps Investor Presentation October 2023
RedChip Companies, Inc.
 
SPI Investor Deck October 2023
SPI Investor Deck October 2023SPI Investor Deck October 2023
SPI Investor Deck October 2023
RedChip Companies, Inc.
 
BFRG Investor Deck September_v2
BFRG Investor Deck September_v2BFRG Investor Deck September_v2
BFRG Investor Deck September_v2
RedChip Companies, Inc.
 
BFRG Investor Deck September
BFRG Investor Deck SeptemberBFRG Investor Deck September
BFRG Investor Deck September
RedChip Companies, Inc.
 
BioVie Presentation September 2023
BioVie Presentation September 2023BioVie Presentation September 2023
BioVie Presentation September 2023
RedChip Companies, Inc.
 
Lantern Pharma September 8, 2023
Lantern Pharma September 8, 2023Lantern Pharma September 8, 2023
Lantern Pharma September 8, 2023
RedChip Companies, Inc.
 
GENE Investor Presentation Genetic Technologies August 2023
GENE Investor Presentation Genetic Technologies August 2023GENE Investor Presentation Genetic Technologies August 2023
GENE Investor Presentation Genetic Technologies August 2023
RedChip Companies, Inc.
 
Splash Beverage Investor Presentation June 2023
Splash Beverage Investor Presentation June 2023Splash Beverage Investor Presentation June 2023
Splash Beverage Investor Presentation June 2023
RedChip Companies, Inc.
 
SEBV Presentation
SEBV PresentationSEBV Presentation
SEBV Presentation
RedChip Companies, Inc.
 

More from RedChip Companies, Inc. (20)

ZOM Investor Presentations Oct 2023
ZOM Investor Presentations Oct 2023ZOM Investor Presentations Oct 2023
ZOM Investor Presentations Oct 2023
 
Docola Presentation
Docola PresentationDocola Presentation
Docola Presentation
 
INNO Holdings Presentation
INNO Holdings PresentationINNO Holdings Presentation
INNO Holdings Presentation
 
EBI IR Presentation Sep 2023
EBI IR Presentation Sep 2023EBI IR Presentation Sep 2023
EBI IR Presentation Sep 2023
 
ASPI Investor Deck Oct 2023
ASPI Investor Deck Oct 2023ASPI Investor Deck Oct 2023
ASPI Investor Deck Oct 2023
 
MDNA Investor Presentation May 2023
MDNA Investor Presentation May 2023MDNA Investor Presentation May 2023
MDNA Investor Presentation May 2023
 
DGLY Corporate Investor Relations Deck Oct 2023
DGLY Corporate Investor Relations Deck Oct 2023DGLY Corporate Investor Relations Deck Oct 2023
DGLY Corporate Investor Relations Deck Oct 2023
 
Lantern Pharma Investor Presentation Oct 2023
Lantern Pharma Investor Presentation Oct 2023Lantern Pharma Investor Presentation Oct 2023
Lantern Pharma Investor Presentation Oct 2023
 
Sharps Investor Deck Oct 2023
Sharps Investor Deck Oct 2023 Sharps Investor Deck Oct 2023
Sharps Investor Deck Oct 2023
 
Aditxt, Inc. (NASDAQ: ADTX) Presentation
Aditxt, Inc. (NASDAQ: ADTX) PresentationAditxt, Inc. (NASDAQ: ADTX) Presentation
Aditxt, Inc. (NASDAQ: ADTX) Presentation
 
1847 Holdings Corporate Presentation 1847 Holdings March 2023
1847 Holdings Corporate Presentation 1847 Holdings March 20231847 Holdings Corporate Presentation 1847 Holdings March 2023
1847 Holdings Corporate Presentation 1847 Holdings March 2023
 
Sharps Investor Presentation October 2023
Sharps  Investor Presentation October 2023Sharps  Investor Presentation October 2023
Sharps Investor Presentation October 2023
 
SPI Investor Deck October 2023
SPI Investor Deck October 2023SPI Investor Deck October 2023
SPI Investor Deck October 2023
 
BFRG Investor Deck September_v2
BFRG Investor Deck September_v2BFRG Investor Deck September_v2
BFRG Investor Deck September_v2
 
BFRG Investor Deck September
BFRG Investor Deck SeptemberBFRG Investor Deck September
BFRG Investor Deck September
 
BioVie Presentation September 2023
BioVie Presentation September 2023BioVie Presentation September 2023
BioVie Presentation September 2023
 
Lantern Pharma September 8, 2023
Lantern Pharma September 8, 2023Lantern Pharma September 8, 2023
Lantern Pharma September 8, 2023
 
GENE Investor Presentation Genetic Technologies August 2023
GENE Investor Presentation Genetic Technologies August 2023GENE Investor Presentation Genetic Technologies August 2023
GENE Investor Presentation Genetic Technologies August 2023
 
Splash Beverage Investor Presentation June 2023
Splash Beverage Investor Presentation June 2023Splash Beverage Investor Presentation June 2023
Splash Beverage Investor Presentation June 2023
 
SEBV Presentation
SEBV PresentationSEBV Presentation
SEBV Presentation
 

Recently uploaded

一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
ybout
 
Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024
Sysco_Investors
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
CollectiveMining1
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
Probe Gold
 
cyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdfcyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdf
CyberAgent, Inc.
 
Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24
Philip Rabenok
 
Snam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial PresentationSnam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial Presentation
Valentina Ottini
 
2024-deutsche-bank-global-consumer-conference.pdf
2024-deutsche-bank-global-consumer-conference.pdf2024-deutsche-bank-global-consumer-conference.pdf
2024-deutsche-bank-global-consumer-conference.pdf
Sysco_Investors
 

Recently uploaded (8)

一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
一比一原版(UW毕业证)华盛顿大学毕业证成绩单专业办理
 
Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
 
cyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdfcyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdf
 
Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24
 
Snam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial PresentationSnam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial Presentation
 
2024-deutsche-bank-global-consumer-conference.pdf
2024-deutsche-bank-global-consumer-conference.pdf2024-deutsche-bank-global-consumer-conference.pdf
2024-deutsche-bank-global-consumer-conference.pdf
 

CDIF investor presentation